Eksunbi (Ustekinumab)

Eksunbi is a biologic medication used to manage moderate to severe plaque psoriasis and other autoimmune conditions. This intravenous treatment helps reduce inflammation and symptoms.

Eksunbi is primarily used for the treatment of moderate to severe plaque psoriasis in adults who are candidates for phototherapy or systemic therapy. It may also be used for other autoimmune conditions where inflammation control is necessary. The medication works by targeting specific proteins in the immune system to reduce inflammation and symptom severity.

Common effects of Eksunbi may include reactions at the injection site, such as redness, swelling, or pain. Some individuals might experience headaches, fatigue, or upper respiratory infections. These effects are generally mild to moderate and may vary among users.

Eksunbi should be used under medical supervision due to its potential to affect the immune system. It is important to discuss any existing health conditions, especially infections or a history of cancer, with a healthcare provider before starting treatment. Regular monitoring may be required during therapy.

Eksunbi may interact with other medications that affect the immune system, including certain vaccines and immunosuppressive drugs. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that impact liver function should be used cautiously.